In contrast, Quetiapine had an estimated β of 1.07 (95% CI: 0.91–1.22), which suggested an increasing trend in AE occurrence over time—consistent with a pattern often linked to late-onset adverse reactions.
← all excerpts
Exploration of the associations between violent and aggressive behaviors risk and NHHR, TyG in patients with schizophrenia: an SHAP interpretable machine learning prediction and FAERS pharmacovigilance analysis.
2
—
—
The sentences
Specifically, Olanzapine had an estimated shape parameter (β) of 0.72 (95% CI: 0.41–1.02); this β value indicated a decreasing trend in AE occurrence over time, a pattern typically associated with early-onset adverse reactions.